Hudson Bay Capital Management LP Abbott Laboratories Transaction History

Hudson Bay Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $4.53 Million - $5.06 Million	45,000 New	45,000 $4.68 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $525,000 - $572,100	-5,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $458,200 - $556,450	5,000 New	5,000 $544,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $13.2 Million - $14.9 Million	-201,198 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $12.2 Million - $14.8 Million	201,198 New	201,198 $14.8 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $14.6 Million - $16.1 Million	-253,539 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $14.3 Million - $16.1 Million	253,539 New	253,539 $15.2 Million

3,224

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.